Ethyol

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2017
051019922017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
PURPOSE The cytoprotective drug amifostine (Ethyol) protects rats from oral mucositis resulting from a single dose of gamma… (More)
Is this relevant?
2004
2004
Amifostine (Ethyol) is a cytoprotective drug approved for the reduction of xerostomia in head and neck cancer when administered… (More)
Is this relevant?
2003
2003
PURPOSE Amifostine (Ethyol) is currently approved for intravenous (IV) administration to prevent xerostomia in patients receiving… (More)
Is this relevant?
2003
2003
Neonatal X-irradiation induces permanent abnormalities in cerebellar cortex cytoarchitecture and neurochemistry, as well as… (More)
Is this relevant?
2003
2003
PURPOSE To evaluate the protective learning and memory effect of Ethyol in irradiated young rats. METHODS AND MATERIALS One… (More)
Is this relevant?
2002
2002
Amifostine (Ethyol) has been evaluated clinically as a radioprotective agent for the prevention of xerostomia and mucositis for… (More)
Is this relevant?
2000
2000
Purpose: Amifostine (WR-2721), a phosphorylated aminothiol pro-drug which is an analogue of cysteamine, is a selective… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1997
1997
The main metabolites of the cytoprotective drug Ethyol (Amifostine, WR-2721) are the thiol WR-1065 and the disulphide WR-33278… (More)
Is this relevant?
1996
1996
Cultured neonatal rat heart myocytes form a synchronously-contracting cell syncytium from one to two days after isolation… (More)
Is this relevant?
1994
1994
This study investigated the metabolism of the radio- and chemoprotector compound, WR-2721 [amifostine; s-2-(3- aminopropylamino… (More)
Is this relevant?